Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elizabeth Anne Mullen, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Liu KX, Collins NB, Greenzang KA, Furutani E, Campbell K, Groves A, Mullen EA, Shusterman S, Spidle J, Marcus KJ, Weil BR, Weldon CB, Frazier AL, Janeway KA, O'Neill AF, Mack JW, DuBois SG, Shulman DS. The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatr Blood Cancer. 2020 Jul 19; e28559. PMID: 32686305.
    Citations:    
  2. Ehrlich PF, Chi YY, Chintagumpala MM, Hoffer FA, Perlman EJ, Kalapurakal JA, Tornwall B, Warwick A, Shamberger RC, Khanna G, Hamilton TE, Gow KW, Paulino AC, Gratias EJ, Mullen EA, Geller JI, Grundy PE, Fernandez CV, Dome JS. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group. Cancer. 2020 Aug 01; 126(15):3516-3525. PMID: 32459384.
    Citations:    
  3. Kamihara J, Paulson V, Breen MA, Laetsch TW, Rakheja D, Shulman DS, Schoettler ML, Clinton CM, Ward A, Reidy D, Pinches RS, Weiser DA, Mullen EA, Schienda J, Meyers PA, DuBois SG, Nowak JA, Foulkes WD, Schultz KAP, Janeway KA, Vargas SO, Church AJ. DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor. Mod Pathol. 2020 Apr 14. PMID: 32291395.
    Citations:    
  4. Parsons LN, Mullen EA, Geller JI, Chi YY, Khanna G, Glick RD, Aldrink JH, Vallance KL, Kim Y, Fernandez CV, Dome JS, Perlman EJ. Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2. Cancer. 2020 Jun 15; 126(12):2866-2871. PMID: 32267967.
    Citations:    
  5. Sandberg JK, Chi YY, Smith EA, Servaes S, Hoffer FA, Mullen EA, Perlman EJ, Tornwall B, Ehrlich PF, Geller JI, Grundy PE, Fernandez CV, Dome JS, Khanna G. Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2. AJR Am J Roentgenol. 2020 05; 214(5):987-994. PMID: 32160052.
    Citations:    
  6. Daw NC, Chi YY, Kalapurakal JA, Kim Y, Hoffer FA, Geller JI, Perlman EJ, Ehrlich PF, Mullen EA, Warwick AB, Grundy PE, Paulino AC, Gratias E, Ward D, Anderson JR, Khanna G, Tornwall B, Fernandez CV, Dome JS. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. J Clin Oncol. 2020 May 10; 38(14):1558-1568. PMID: 32134700.
    Citations:    
  7. Forrest SJ, Al-Ibraheemi A, Doan D, Ward A, Clinton CM, Putra J, Pinches RS, Kadoch C, Chi SN, DuBois SG, Leavey PJ, LeBoeuf NR, Mullen E, Collins N, Church AJ, Janeway KA. Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers. Clin Cancer Res. 2020 Jun 15; 26(12):2882-2890. PMID: 32122923.
    Citations:    
  8. Campbell K, Mullen E. 50 Years Ago in TheJournal ofPediatrics: 50 years of progress in renal cell carcinoma: From case reports to targeted therapy. J Pediatr. 2020 Mar; 218:120. PMID: 32089177.
    Citations:    
  9. Dix DB, Fernandez CV, Chi YY, Mullen EA, Geller JI, Gratias EJ, Khanna G, Kalapurakal JA, Perlman EJ, Seibel NL, Ehrlich PF, Malogolowkin M, Anderson J, Gastier-Foster J, Shamberger RC, Kim Y, Grundy PE, Dome JS. Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report. J Clin Oncol. 2019 10 20; 37(30):2769-2777. PMID: 31449468.
    Citations:    
  10. Ortiz MV, Ahmed S, Burns M, Henssen AG, Hollmann TJ, MacArthur I, Gunasekera S, Gaewsky L, Bradwin G, Ryan J, Letai A, He Y, Naranjo A, Chi YY, LaQuaglia M, Heaton T, Cifani P, Dome JS, Gadd S, Perlman E, Mullen E, Steen H, Kentsis A. Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor. JCI Insight. 2019 08 08; 4(15). PMID: 31391345.
    Citations:    
  11. Daw NC, Chi YY, Kim Y, Mullen EA, Kalapurakal JA, Tian J, Khanna G, Geller JI, Perlman EJ, Ehrlich PF, Warwick AB, Grundy PE, Fernandez CV, Dome JS. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study. Eur J Cancer. 2019 09; 118:58-66. PMID: 31325873.
    Citations:    
  12. Mullen EA, Khanna G, Geller JI, Fernandez CV, Dome JS. Reply to L. Xie et al. J Clin Oncol. 2019 05 10; 37(14):1264-1265. PMID: 30875281.
    Citations:    
  13. Hong AL, Tseng YY, Wala JA, Kim WJ, Kynnap BD, Doshi MB, Kugener G, Sandoval GJ, Howard TP, Li J, Yang X, Tillgren M, Ghandi M, Sayeed A, Deasy R, Ward A, McSteen B, Labella KM, Keskula P, Tracy A, Connor C, Clinton CM, Church AJ, Crompton BD, Janeway KA, Van Hare B, Sandak D, Gjoerup O, Bandopadhayay P, Clemons PA, Schreiber SL, Root DE, Gokhale PC, Chi SN, Mullen EA, Roberts CW, Kadoch C, Beroukhim R, Ligon KL, Boehm JS, Hahn WC. Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition. Elife. 2019 03 12; 8. PMID: 30860482.
    Citations:    
  14. Mullen EA, Chi YY, Hibbitts E, Anderson JR, Steacy KJ, Geller JI, Green DM, Khanna G, Malogolowkin MH, Grundy PE, Fernandez CV, Dome JS. Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. J Clin Oncol. 2018 Oct 18; JCO1800076. PMID: 30335557.
    Citations:    Fields:    
  15. Dix DB, Seibel NL, Chi YY, Khanna G, Mullen EA, Geller JI, Kalapurakal JA, Ehrlich PF, Malogolowkin MH, Fernandez CV, Dome JS. Reply to D.M. Green. J Clin Oncol. 2018 Sep 13; JCO1800659. PMID: 30212299.
    Citations:    Fields:    
  16. Msaouel P, Hong AL, Mullen EA, Atkins MB, Walker CL, Lee CH, Carden MA, Genovese G, Linehan WM, Rao P, Merino MJ, Grodman H, Dome JS, Fernandez CV, Geller JI, Apolo AB, Daw NC, Hodges HC, Moxey-Mims M, Wei D, Bottaro DP, Staehler M, Karam JA, Rathmell WK, Tannir NM. Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma. Clin Genitourin Cancer. 2019 02; 17(1):1-6. PMID: 30287223.
    Citations:    Fields:    
  17. Klega K, Imamovic-Tuco A, Ha G, Clapp AN, Meyer S, Ward A, Clinton C, Nag A, Van Allen E, Mullen E, DuBois SG, Janeway K, Meyerson M, Thorner AR, Crompton BD. Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. JCO Precis Oncol. 2018; 2018. PMID: 30027144.
    Citations:    
  18. Cajaiba MM, Dyer LM, Geller JI, Jennings LJ, George D, Kirschmann D, Rohan SM, Cost NG, Khanna G, Mullen EA, Dome JS, Fernandez CV, Perlman EJ. The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing. Cancer. 2018 08; 124(16):3381-3389. PMID: 29905933.
    Citations:    Fields:    
  19. Dix DB, Seibel NL, Chi YY, Khanna G, Gratias E, Anderson JR, Mullen EA, Geller JI, Kalapurakal JA, Paulino AC, Perlman EJ, Ehrlich PF, Malogolowkin M, Gastier-Foster JM, Wagner E, Grundy PE, Fernandez CV, Dome JS. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. J Clin Oncol. 2018 06 01; 36(16):1564-1570. PMID: 29659330.
    Citations: 2     Fields:    
  20. Fernandez CV, Perlman EJ, Gastier-Foster J, Geller JI, Mullen EA, Ehrlich PF, Dome JS. Reply to B. Zhang et al. J Clin Oncol. 2018 05 10; 36(14):1454-1455. PMID: 29613833.
    Citations:    Fields:    
  21. Fernandez CV, Mullen EA, Chi YY, Ehrlich PF, Perlman EJ, Kalapurakal JA, Khanna G, Paulino AC, Hamilton TE, Gow KW, Tochner Z, Hoffer FA, Withycombe JS, Shamberger RC, Kim Y, Geller JI, Anderson JR, Grundy PE, Dome JS. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. J Clin Oncol. 2018 01 20; 36(3):254-261. PMID: 29211618.
    Citations: 3     Fields:    
  22. Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodríguez-Fos E, Gonzalez S, Puiggròs M, Blackford AN, Mason CE, de Stanchina E, Gönen M, Emde AK, Shah M, Arora K, Reeves C, Socci ND, Perlman E, Antonescu CR, Roberts CWM, Steen H, Mullen E, Jackson SP, Torrents D, Weng Z, Armstrong SA, Kentsis A. Erratum: PGBD5 promotes site-specific oncogenic mutations in human tumors. Nat Genet. 2017 09 27; 49(10):1558. PMID: 28951624.
    Citations:    Fields:    
  23. Ehrlich P, Chi YY, Chintagumpala MM, Hoffer FA, Perlman EJ, Kalapurakal JA, Warwick A, Shamberger RC, Khanna G, Hamilton TE, Gow KW, Paulino AC, Gratias EJ, Mullen EA, Geller JI, Grundy PE, Fernandez CV, Ritchey ML, Dome JS. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group. Ann Surg. 2017 09; 266(3):470-478. PMID: 28795993.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  24. Sandberg JK, Mullen EA, Cajaiba MM, Smith EA, Servaes S, Perlman EJ, Geller JI, Ehrlich PF, Cost NG, Dome JS, Fernandez CV, Khanna G. Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group. Pediatr Radiol. 2017 Nov; 47(12):1615-1621. PMID: 28689245.
    Citations:    Fields:    Translation:Humans
  25. Beckermann KE, Sharma D, Chaturvedi S, Msaouel P, Abboud MR, Allory Y, Bourdeaut F, Calderaro J, de Cubas AA, Derebail VK, Hong AL, Naik RP, Malouf GG, Mullen EA, Reuter VE, Roberts CWM, Walker CL, Wood CG, DeBaun MR, Van Poppel H, Tannir NM, Rathmell WK. Renal Medullary Carcinoma: Establishing Standards in Practice. J Oncol Pract. 2017 07; 13(7):414-421. PMID: 28697319.
    Citations:    Fields:    Translation:Humans
  26. Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodríguez-Fos E, Gonzalez S, Puiggròs M, Blackford AN, Mason CE, de Stanchina E, Gönen M, Emde AK, Shah M, Arora K, Reeves C, Socci ND, Perlman E, Antonescu CR, Roberts CWM, Steen H, Mullen E, Jackson SP, Torrents D, Weng Z, Armstrong SA, Kentsis A. PGBD5 promotes site-specific oncogenic mutations in human tumors. Nat Genet. 2017 Jul; 49(7):1005-1014. PMID: 28504702.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  27. Fernandez CV, Perlman EJ, Mullen EA, Chi YY, Hamilton TE, Gow KW, Ferrer FA, Barnhart DC, Ehrlich PF, Khanna G, Kalapurakal JA, Bocking T, Huff V, Tian J, Geller JI, Grundy PE, Anderson JR, Dome JS, Shamberger RC. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532. Ann Surg. 2017 04; 265(4):835-840. PMID: 27811504.
    Citations: 7     Fields:    Translation:Humans
  28. Yi JS, Kamihara J, Kesselheim JC, Davies K, van Hoff J, Silverman LB, Mullen EA. Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan. Pediatr Blood Cancer. 2017 05; 64(5). PMID: 27862952.
    Citations:    Fields:    Translation:Humans
  29. Gratias EJ, Dome JS, Jennings LJ, Chi YY, Tian J, Anderson J, Grundy P, Mullen EA, Geller JI, Fernandez CV, Perlman EJ. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. J Clin Oncol. 2016 09 10; 34(26):3189-94. PMID: 27400937.
    Citations: 8     Fields:    Translation:HumansCells
  30. Ehrlich PF, Hamilton TE, Gow K, Barnhart D, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Perlman EJ, Kalapurakal JA, Khanna G, Dome JS, Geller J, Mullen E. Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2016 11; 63(11):1905-10. PMID: 27229358.
    Citations: 3     Fields:    Translation:Humans
  31. Cajaiba MM, Khanna G, Smith EA, Gellert L, Chi YY, Mullen EA, Hill DA, Geller JI, Dome JS, Perlman EJ. Pediatric cystic nephromas: distinctive features and frequent DICER1 mutations. Hum Pathol. 2016 Feb; 48:81-7. PMID: 26772403.
    Citations: 3     Fields:    Translation:Humans
  32. Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, Van den Heuvel-Eibrink M, Pritchard-Jones K. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. J Clin Oncol. 2015 Sep 20; 33(27):2999-3007. PMID: 26304882.
    Citations: 24     Fields:    Translation:Humans
  33. Geller JI, Ehrlich PF, Cost NG, Khanna G, Mullen EA, Gratias EJ, Naranjo A, Dome JS, Perlman EJ. Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2. Cancer. 2015 Jul 15; 121(14):2457-64. PMID: 25845370.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  34. Servaes S, Khanna G, Naranjo A, Geller JI, Ehrlich PF, Gow KW, Perlman EJ, Dome JS, Gratias E, Mullen EA. Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group. Pediatr Radiol. 2015 Feb; 45(2):166-72. PMID: 25135711.
    Citations:    Fields:    Translation:Humans
  35. Ferrer FA, Herbst KW, Fernandez CV, Khanna G, Dome JS, Naranjo A, Mullen EA, Geller JI, Gratias EJ, Shamberger R, Ritchey M, Ehrlich PF. Feasibility of using CT volume as a predictor of specimen weight in a subgroup of patients with low risk Wilms tumors registered on COG Study AREN03B2: implications for central venous catheter placement. J Pediatr Urol. 2014 Oct; 10(5):969-73. PMID: 24863984.
    Citations:    Fields:    Translation:Humans
  36. Doros LA, Rossi CT, Yang J, Field A, Williams GM, Messinger Y, Cajaiba MM, Perlman EJ, A Schultz K, Cathro HP, Legallo RD, LaFortune KA, Chikwava KR, Faria P, Geller JI, Dome JS, Mullen EA, Gratias EJ, Dehner LP, Hill DA. DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol. 2014 Sep; 27(9):1267-80. PMID: 24481001.
    Citations: 38     Fields:    Translation:Humans
  37. Hamilton TE, Barnhart D, Gow K, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Gratias E, Geller J, Mullen E, Ehrlich P. Inter-rater reliability of surgical reviews for AREN03B2: a COG renal tumor committee study. J Pediatr Surg. 2014 Jan; 49(1):154-8; discussion 158. PMID: 24439601.
    Citations:    Fields:    Translation:Humans
  38. Armon BD, Mullen EA. Uncle Sam and your job options. Considering your next career move? Consider the tax implications. Del Med J. 2013 May; 85(5):147-9. PMID: 23858982.
    Citations:    Fields:    Translation:Humans
  39. Gow KW, Barnhart DC, Hamilton TE, Kandel JJ, Chen MK, Ferrer FA, Price MR, Mullen EA, Geller JI, Gratias EJ, Rosen N, Khanna G, Naranjo A, Ritchey ML, Grundy PE, Dome JS, Ehrlich PF. Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee. J Pediatr Surg. 2013 Jan; 48(1):34-8. PMID: 23331790.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  40. Dome JS, Fernandez CV, Mullen EA, Kalapurakal JA, Geller JI, Huff V, Gratias EJ, Dix DB, Ehrlich PF, Khanna G, Malogolowkin MH, Anderson JR, Naranjo A, Perlman EJ. Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer. 2013 Jun; 60(6):994-1000. PMID: 23255438.
    Citations: 24     Fields:    Translation:Humans
  41. Khanna G, Naranjo A, Hoffer F, Mullen E, Geller J, Gratias EJ, Ehrlich PF, Perlman EJ, Rosen N, Grundy P, Dome JS. Detection of preoperative wilms tumor rupture with CT: a report from the Children's Oncology Group. Radiology. 2013 Feb; 266(2):610-7. PMID: 23192775.
    Citations: 4     Fields:    Translation:Humans
  42. Fernandez CV, Li N, Mullen EA, Grundy PE, Perman EJ, Shamberger RC, Ehrlich PF, Dome JS. Barriers to the enrollment of children in the Children's Oncology Group study of very low risk Wilms tumor: a report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2011 Oct; 33(7):521-3. PMID: 21941145.
    Citations: 3     Fields:    Translation:Humans
  43. Mullen EA, Anderson JR, Steacy KJ, Geller JI, Green DM, Norkool P, Fernandez CV, Khanna G, Malogolowkin MH, Dome J. The impact of surveillance imaging on overall survival in patients with recurrent Wilms tumor: A report from the Children's Oncology Group. J Clin Oncol. 2011 May 20; 29(15_suppl):9536. PMID: 28019786.
    Citations:    
  44. Metzger ML, Stewart CF, Freeman BB, Billups CA, Hoffer FA, Wu J, Coppes MJ, Grant R, Chintagumpala M, Mullen EA, Alvarado C, Daw NC, Dome JS. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study. J Clin Oncol. 2007 Jul 20; 25(21):3130-6. PMID: 17634492.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  45. E A Mullen. Pediatric Oncologic Emergencies. Nathan & Oski's Hematology Textbook of Infancy and Childhood. 2007; In Press.
  46. Wang Y, Sands LP, Vaurio L, Mullen EA, Leung JM. The effects of postoperative pain and its management on postoperative cognitive dysfunction. Am J Geriatr Psychiatry. 2007 Jan; 15(1):50-9. PMID: 17194815.
    Citations: 22     Fields:    Translation:Humans
  47. Mullen E, Skitka LJ. Exploring the psychological underpinnings of the moral mandate effect: motivated reasoning, group differentiation, or anger? J Pers Soc Psychol. 2006 Apr; 90(4):629-43. PMID: 16649859.
    Citations: 3     Fields:    Translation:Humans
  48. Kolden GG, Chisholm-Stockard SM, Strauman TJ, Tierney SC, Mullen EA, Schneider KL. Universal session-level change processes in an early session of psychotherapy: path models. J Consult Clin Psychol. 2006 Apr; 74(2):327-36. PMID: 16649877.
    Citations: 5     Fields:    Translation:Humans
  49. EA Mullen. Section Editor, Oncology. Pediatric Hospitalist Textbook, Chiang. 2006.
  50. EA Mullen. Oncologic Emergencies Chapter. Pediatric Hospitalist Textbook, Chiang. 2006.
  51. Vaurio LE, Sands LP, Wang Y, Mullen EA, Leung JM. Postoperative delirium: the importance of pain and pain management. Anesth Analg. 2006 Apr; 102(4):1267-73. PMID: 16551935.
    Citations: 43     Fields:    Translation:Humans
  52. Mullen EA. Section Editor, Oncology. Pediatric Hospitalist Textbook. 2006.
  53. B Mueller, M Dinu, R Bryant, E Mullen J Yan, C Brugnara. The Safety of Oral Magnesium Pidolate in Children with Hemoglobin SC Disease. Presented at the 28th Annual Meeting of the National Sickle Cell Disease Program. 2005.
  54. Jones M, Campbell KA, Duggan C, Young G, Bousvaros A, Higgins L, Mullen E. Multiple micronutrient deficiencies in a child fed an elemental formula. J Pediatr Gastroenterol Nutr. 2001 Nov; 33(5):602-5. PMID: 11740236.
    Citations: 2     Fields:    Translation:Humans
  55. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines on the treatment of patients with Sickle Cell Disease, on the topic of Transfusion. 2001.
  56. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clincial Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Acute Chest. 2001.
  57. Jones, Monica; Campbell, Katie A.; Duggan, Christopher; Young, Gregory; Bousvaros, Athos; Higgins, Laurie; Mullen, Elizabeth . Multiple Micronutrient Deficiencies in a Child Fed an Elemental Formula. Journal of Pediatric Oncology. 2001; (5):602-605.
  58. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Splenic Sequestration. 2000.
  59. E. Mullen, Co-Author, and the Children's Hospital Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of Fever and Neutropenia. 2000.
  60. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Pain. 2000.
  61. E. Mullen, Co-Author, and the Children's Hospital Clinical Practice Guideline Committee. . Clinical Practice Guidelines for the treatment of Pain in Sickle Cell Disease. 2000.
  62. E. Mullen, Lead Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Fever. 2000.
  63. E. Mullen, Co-Author, and the New England Pediatric Sickle Cell Consortium Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of patients with Sickle Cell Disease, on the topic of Routine Health Maintainence and Priapism. 2000.
  64. E. Mullen, Lead Author, and the Children's Hospital Clinical Practice Guideline Committee. Clinical Practice Guidelines for the treatment of Fever in Sickle Cell Disease. 2000.
  65. Szabo S, Pihan G, Raza A, Mullen EA, Hauschka PV. Multiple Mechanisms of Cell Injury in the Gastric Mucosa. Federal Proceedings. 1991; 46:1152.
  66. Mullen EA. Biochemical Characterization of a Boving Corneal Angiogenesis Inhibitor. 1991.
  67. Mullen EA, McKee MD, Hauschka PV. . Fluorogenic Assay of Proteinase Activity in Developing Rat Enamel. Journal of Dental Research. 1989; 68:239.
  68. Hauschka PV, Mullen EA, Hintsch G, Jazwinski S. Abundant Occurrence of Gamma-Carboxyglutamic Acid-Containing Peptides in the Gastropod Family. Current Advances in Vitamin K Research. Ed. John Suttie. 1988.
  69. Mullen, EA. An examination of the Vitamin K Cycle: Phenytoin Interference in K-dependent Carboxylase Activity. 1985.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mullen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (199)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.